Recent aspects of medical care of malignant melanoma
- PMID: 18992025
- DOI: 10.1111/j.1610-0387.2008.06811.x
Recent aspects of medical care of malignant melanoma
Abstract
Recent developments in the epidemiology, diagnosis and therapy of malignant melanoma are reviewed, with particular attention paid to established standards of care. When melanoma metastases are inoperable, they respond poorly to the various chemotherapy strategies, so that additional improvements are critically needed. Cytotoxic T-lymphocyte antigen-4 antibodies, multikinase inhibitors, anti-apoptotic strategies and several other approaches are in progress in Phase III trials both as monotherapy as well as in combination with standard chemotherapy.
Similar articles
-
[Working group of the Dermatologic Oncology].J Dtsch Dermatol Ges. 2009 Aug;7(8):726-7. doi: 10.1111/j.1610-0387.2009.07189.x. J Dtsch Dermatol Ges. 2009. PMID: 19708958 German. No abstract available.
-
Short German guidelines: malignant melanoma.J Dtsch Dermatol Ges. 2008 May;6 Suppl 1:S9-S14. doi: 10.1111/j.1610-0387.2008.06711.x. J Dtsch Dermatol Ges. 2008. PMID: 18801142 English, German. No abstract available.
-
Diagnosis and treatment of cutaneous melanoma: state of the art 2006.Melanoma Res. 2007 Apr;17(2):117-27. doi: 10.1097/CMR.0b013e328042bb36. Melanoma Res. 2007. PMID: 17496787 Review.
-
S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version.J Dtsch Dermatol Ges. 2013 Jun;11(6):563-602. doi: 10.1111/ddg.12044. J Dtsch Dermatol Ges. 2013. PMID: 23721604 No abstract available.
-
Melanoma: epidemiology, diagnosis, treatment, and outcomes.Dermatol Clin. 2012 Jan;30(1):113-24, ix. doi: 10.1016/j.det.2011.08.006. Epub 2011 Oct 19. Dermatol Clin. 2012. PMID: 22117873 Review.
Cited by
-
Melanocyte-specific gene 1 promotes melanoma progression by enhancing the expression of Bcl-2.Oncol Lett. 2018 Feb;15(2):2413-2418. doi: 10.3892/ol.2017.7592. Epub 2017 Dec 12. Oncol Lett. 2018. PMID: 29434952 Free PMC article.
-
Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells.Transl Oncol. 2010 Aug 1;3(4):204-17. doi: 10.1593/tlo.09316. Transl Oncol. 2010. PMID: 20689762 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical